Evoke Pharma
EVOK
EVOK
22 hedge funds and large institutions have $2.56M invested in Evoke Pharma in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
68% less capital invested
Capital invested by funds: $7.91M → $2.56M (-$5.36M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$144K | |
| 2 | +$139K | |
| 3 | +$118K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$65K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$63K |
Top Sellers
| 1 | -$3.5M | |
| 2 | -$682K | |
| 3 | -$283K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$54.6K |
| 5 |
Morgan Stanley
New York
|
-$10.4K |